212 related articles for article (PubMed ID: 22336657)
1. Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma.
Huang SF; Cheng SD; Chuang WY; Chen IH; Liao CT; Wang HM; Hsieh LL
World J Surg Oncol; 2012 Feb; 10():40. PubMed ID: 22336657
[TBL] [Abstract][Full Text] [Related]
2. G1/S-specific cyclin-D1 might be a prognostic biomarker for patients with laryngeal squamous cell carcinoma.
Zhang YY; Xu ZN; Wang JX; Wei DM; Pan XL
Asian Pac J Cancer Prev; 2012; 13(5):2133-7. PubMed ID: 22901182
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of cyclin D1 and E-cadherin expression in laryngeal squamous cell carcinoma.
Ahmed RA; Shawky Ael-A; Hamed RH
Pathol Oncol Res; 2014 Jul; 20(3):625-33. PubMed ID: 24470282
[TBL] [Abstract][Full Text] [Related]
4. Prognostics of Cyclin-D1 expression with chemoradiation response in patients of locally advanced oral squamous cell carcinoma.
Khan H; Gupta S; Husain N; Misra S; Singh N; Negi MP
J Cancer Res Ther; 2014; 10(2):258-64. PubMed ID: 25022375
[TBL] [Abstract][Full Text] [Related]
5. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 overexpression is associated with poor clinicopathological outcome and survival in oral squamous cell carcinoma in Asian populations: insights from a meta-analysis.
Zhao Y; Yu D; Li H; Nie P; Zhu Y; Liu S; Zhu M; Fang B
PLoS One; 2014; 9(3):e93210. PubMed ID: 24675814
[TBL] [Abstract][Full Text] [Related]
7. Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance.
Carlos de Vicente J; Herrero-Zapatero A; Fresno MF; López-Arranz JS
Oral Oncol; 2002 Apr; 38(3):301-8. PubMed ID: 11978554
[TBL] [Abstract][Full Text] [Related]
8. p53, Cyclin D1, p21 (WAF1) and Ki-67 (MIB1) Expression at Invasive Tumour Fronts of Oral Squamous Cell Carcinomas and Development of Local Recurrence.
Sawair F; Hassona Y; Irwin C; Stephenson M; Hamilton P; Maxwell P; Gordon D; Leonard A; Napier S
Asian Pac J Cancer Prev; 2016; 17(3):1243-9. PubMed ID: 27039754
[TBL] [Abstract][Full Text] [Related]
9. Expression of cyclin D1 is correlated with poor prognosis in patients with areca quid chewing-related oral squamous cell carcinomas in Taiwan.
Kuo MY; Lin CY; Hahn LJ; Cheng SJ; Chiang CP
J Oral Pathol Med; 1999 Apr; 28(4):165-9. PubMed ID: 10235369
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of tumor cyclin D1 expression in oral cancer.
Ramos-García P; González-Moles MÁ; González-Ruiz L; Ayén Á; Ruiz-Ávila I; Bravo M; Gil-Montoya JA
Arch Oral Biol; 2019 Mar; 99():177-182. PubMed ID: 30721793
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of galectin-3 and cyclin D1 expression in undifferentiated nasopharyngeal carcinoma.
Acikalin MF; Etiz D; Gurbuz MK; Ozudogru E; Canaz F; Colak E
Med Oncol; 2012 Jun; 29(2):742-9. PubMed ID: 21553103
[TBL] [Abstract][Full Text] [Related]
12. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.
Zhang H; Zhang J; Nan X; Li X; Qu J; Hong Y; Sun L; Chen Y; Li T
Tumour Biol; 2015 Sep; 36(10):7849-58. PubMed ID: 25946973
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and clinicopathological significance of cyclin D1 expression in oral squamous cell carcinoma: A systematic review and meta-analysis.
Ramos-García P; González-Moles MÁ; González-Ruiz L; Ruiz-Ávila I; Ayén Á; Gil-Montoya JA
Oral Oncol; 2018 Aug; 83():96-106. PubMed ID: 30098785
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1-CDK4 complex, a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas.
Dong Y; Sui L; Sugimoto K; Tai Y; Tokuda M
Int J Cancer; 2001 Jul; 95(4):209-15. PubMed ID: 11400112
[TBL] [Abstract][Full Text] [Related]
15. Significance of cytoplasmic cyclin D1 expression in oral oncogenesis.
Ramos-García P; Bravo M; González-Ruiz L; González-Moles MÁ
Oral Dis; 2018 Mar; 24(1-2):98-102. PubMed ID: 29480608
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical Expression of Cyclin D1 and Ki-67 in Primary and Metastatic Oral Squamous Cell Carcinoma.
Nazar M; Naz I; Mahmood MK; Hashmi SN
Asian Pac J Cancer Prev; 2020 Jan; 21(1):37-41. PubMed ID: 31983161
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 amplification in tongue and cheek squamous cell carcinoma.
Mahdey HM; Ramanathan A; Ismail SM; Abraham MT; Jamaluddin M; Zain RB
Asian Pac J Cancer Prev; 2011; 12(9):2199-204. PubMed ID: 22296356
[TBL] [Abstract][Full Text] [Related]
18. Cyclin d1 expression and its correlation with histopathological differentiation in oral squamous cell carcinoma.
Saawarn S; Astekar M; Saawarn N; Dhakar N; Gomateshwar Sagari S
ScientificWorldJournal; 2012; 2012():978327. PubMed ID: 22629227
[TBL] [Abstract][Full Text] [Related]
19. Increased LDH5 expression is associated with lymph node metastasis and outcome in oral squamous cell carcinoma.
Grimm M; Alexander D; Munz A; Hoffmann J; Reinert S
Clin Exp Metastasis; 2013 Apr; 30(4):529-40. PubMed ID: 23184277
[TBL] [Abstract][Full Text] [Related]
20. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
Laco J; Nekvindova J; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Vosmikova H; Vosmik M; Neskudlova T; Cermakova E; Hacova M; Sobande FA; Ryska A
Neoplasma; 2012; 59(4):398-408. PubMed ID: 22489695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
